Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma

作者: Nikolina Radulovich , Nhu-An Pham , Dan Strumpf , Lisa Leung , Wing Xie

DOI: 10.1186/1476-4598-9-24

关键词:

摘要: The cyclin D1 (CCND1) and D3 (CCND3) are frequently co-overexpressed in pancreatic ductal adenocarcinoma (PDAC). Here we examine their differential roles PDAC. CCND1 CCND3 expression were selectively suppressed by shRNA PDAC cell lines with levels of equal (BxPC3), enhanced (HPAC) or (PANC1). Suppression proliferation was greater than downregulation. suppression led to a reduced level phosphorylated retinoblastoma protein (Ser795p-Rb/p110) resulted decreased A mRNA protein. global gene analysis identified deregulated genes D1- D3-cyclin siRNA-treated PANC1 cells. downregulated targets cells significantly enriched cycle associated processes (p < 0.005). In contrast, focal adhesion/actin cytoskeleton, MAPK NF B signaling appeared characterize the target interacting proteins Our results suggest that is primary driver cycle, cooperation integrates extracellular mitogenic signaling. We also present evidence plays role tumor migration. provide novel insights for common overexpression during duct carcinogenesis.

参考文章(54)
Gang Jin, Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays World Journal of Gastroenterology. ,vol. 11, pp. 6543- 6548 ,(2005) , 10.3748/WJG.V11.I41.6543
Andreas-Claudius Hoffmann, Ryutaro Mori, Daniel Vallbohmer, Jan Brabender, Ellen Klein, Uta Drebber, Stephan E. Baldus, Janine Cooc, Mizutomo Azuma, Ralf Metzger, Arnulf H. Hoelscher, Kathleen D. Danenberg, Klaus L Prenzel, Peter V. Danenberg, High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia. ,vol. 10, pp. 674- 679 ,(2008) , 10.1593/NEO.08292
Ralph H. Hruban, Irmgard Schwarte-Waldhoff, Joseph Geradts, Mieke Schutte, Wolff Schmiegel, Stephen B. Baylin, Werner Hilgers, Stephan A. Hahn, Scott E. Kern, James G. Herman, Rob Maynard, Christopher A. Moskaluk, Sridhar K. Rabindran, Abrogation of the Rb/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas Cancer Research. ,vol. 57, pp. 3126- 3130 ,(1997)
Jo Vandesompele, Katleen De Preter, Filip Pattyn, Bruce Poppe, Nadine Van Roy, Anne De Paepe, Frank Speleman, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biology. ,vol. 3, pp. 1- 12 ,(2002) , 10.1186/GB-2002-3-7-RESEARCH0034
Sandra A. Biankin, James G. Kench, Susan M. Henshall, C.-Soon Lee, Adrienne L. Morey, Darren R. Head, Andrew V. Biankin, Robert L. Sutherland, Thomas B. Hugh, Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia Cancer Research. ,vol. 61, pp. 8830- 8837 ,(2001)
T. Delohery, A. Sgambato, Y. Doki, M. G. Klein, P. R. Holt, E. K.-H. Han, I. B. Weinstein, N. Arber, N.-H. Kim, P. Zhou, Antisense to Cyclin D1 Inhibits the Growth and Tumorigenicity of Human Colon Cancer Cells Cancer Research. ,vol. 57, pp. 1569- 1574 ,(1997)
Elizabeth A. Musgrove, Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors Journal. ,vol. 24, pp. 13- 19 ,(2006) , 10.1080/08977190500361812
Jeffrey Kreisberg, Shazli Malik, Shujie Zhao, James W Freeman, Daniel DeArmond, Michael G Brattain, John Milburn Jessup, Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines Oncogene. ,vol. 22, pp. 7781- 7795 ,(2003) , 10.1038/SJ.ONC.1206966
Matthias P. A. Ebert, Sara Hernberg, Guo Fei, Armin Sokolowski, Hans U. Schulz, Hans Lippert, Peter Malfertheiner, Induction and expression of cyclin D3 in human pancreatic cancer Journal of Cancer Research and Clinical Oncology. ,vol. 127, pp. 449- 454 ,(2001) , 10.1007/S004320100235
Marie Chaussepied, Doron Ginsberg, Transcriptional regulation of AKT activation by E2F. Molecular Cell. ,vol. 16, pp. 831- 837 ,(2004) , 10.1016/J.MOLCEL.2004.11.003